Skip to main content

Advertisement

SpringerLink
Log in

Simian virus 40 and its association with human lymphomas

  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Simian virus 40 (SV40) is a potent DNA tumor virus that is known to induce cancer in laboratory animals. The neoplasias induced by SV40 in animal models are brain cancers, mesothelioma, bone cancers, and systemic lymphomas. SV40 oncogenesis is mediated primarily by the viral large tumor antigen, which inactivates the tumor suppressor proteins p53 and pRb family members. Evidence indicates that SV40 is an emergent human pathogen and that a significant excess risk of SV40 is associated with primary human brain cancers, malignant mesothelioma, bone cancers, and non-Hodgkin’s lymphoma. Therefore, the major types of tumors induced by SV40 in laboratory animals are the same as those human malignancies found to contain SV40 markers. Experimental and clinical data indicate that SV40 may be functionally important in the development of some of those malignancies. Recently, the Institute of Medicine of the National Academies concluded that SV40 infections could lead to cancer in humans under natural conditions (based on moderate strength biologic evidence). This review examines the data implicating SV40 in the pathogenesis of human lymphomas and discusses future directions to define the causative role for SV40 in these malignancies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Jemal A, Thomas A, Murray T, Thun M: Cancer statistics, 2002. CA Cancer J Clin 2002, 52:23–47.

    Article  PubMed  Google Scholar 

  2. Mitsuyasu R: Oncological complications of human immunodeficiency virus disease and hematologic consequences of their treatment. Clin Infect Dis 1999, 29:35–43.

    PubMed  CAS  Google Scholar 

  3. Butel JS: Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 2000, 21:405–426. This is a comprehensive review of the mechanisms of viruses and human malignancies. The author reviews the role of tumor viruses in the discovery of the genetic basis of cancer and in the pathogenesis and etiology of human cancer.

    Article  PubMed  CAS  Google Scholar 

  4. Vilchez RA, Kozinetz CA, Jorgensen JL, et al.: AIDS-related systemic non-Hodgkin’s lymphoma at a large community program. AIDS Res Hum Retroviruses 2002, 18:237–242.

    Article  PubMed  Google Scholar 

  5. Cesarman E, Knowles DM: Kaposi’s sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi’s sarcoma, primary effusion lymphoma, and multicentric Castleman’s disease. Semin Diagn Pathol 1997, 14:54–66.

    PubMed  CAS  Google Scholar 

  6. Gerard L, Agbalika F, Sheldon J, et al.: No increased human herpesvirus 8 seroprevalence in patients with HIV-associated non-Hodgkin’s lymphoma. J Acquir Immune Defic Syndr 2001, 26:182–184.

    Article  PubMed  CAS  Google Scholar 

  7. Vilchez RA, Madden CR, Kozinetz CA, et al.: Association between simian virus 40 and non-Hodgkin lymphoma. Lancet 2002, 359:817–823. This controlled molecular study conclusively established a significant association of SV40 with non-Hodgkin’s lymphoma among HIVinfected and uninfected patients.

    Article  PubMed  CAS  Google Scholar 

  8. David H, Mendoza S, Konishi T, Miller CW: Simian virus 40 is present in human lymphomas and normal blood. Cancer Lett 2001, 162:57–64. This controlled study provided evidence of an association of SV40 and human lymphomas.

    Article  PubMed  CAS  Google Scholar 

  9. Shivapurkar N, Harada K, Reddy J, et al.: Presence of simian virus 40 DNA sequences in human lymphomas. Lancet 2002, 359:851–852. This controlled study confirmed the association of SV40 with non-Hodgkin’s lymphoma.

    Article  PubMed  CAS  Google Scholar 

  10. Martini F, Dolcetti R, Gloghini A, et al.: Simian-virus-40 footprints in human lymphoproliferative disorders of HIV- and HIV+ patients. Int J Cancer 1998, 78:669–674.

    Article  PubMed  CAS  Google Scholar 

  11. Rizzo P, Carbone M, Fisher SG, et al.: Simian virus 40 is present in most United States human mesotheliomas, but it is rarely present in non-Hodgkin’s lymphoma. Chest 1999, 116:470S-473S.

    Article  PubMed  CAS  Google Scholar 

  12. Vilchez RA, Kozinetz CA, Arrington AS, et al.: Simian virus 40 in human cancers. Am J Med 2003, 114:675–684. This systematic analysis of molecular and clinical data conclusively showed an excess risk of SV40 and selected human malignancies (brain and bone tumors, mesotheliomas, and non-Hodgkin’s lymphoma).

    Article  PubMed  Google Scholar 

  13. Stratton K, Almario DA, McCormick MC: Immunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer. Washington, DC: The National Academies Press; 2003, in press.

    Google Scholar 

  14. Vilchez RA, Kozinetz CA, Butel JS: Conventional epidemiology and the link between SV40 and human cancers. Lancet Oncol 2003, 4:188–191. This article provides a comprehensive analysis of epidemiologic studies of human exposure to SV40 through contaminated polio vaccines and the risk of cancer. The analysis showed the significant limitations of epidemiologic studies to address SV40 causality of human cancer.

    Article  PubMed  CAS  Google Scholar 

  15. Butel JS, Lednicky JA: Cell and molecular biology of simian virus 40: implications for human infections and disease. J Natl Cancer Inst 1999, 91:119–134.

    Article  PubMed  CAS  Google Scholar 

  16. Rollison DEM, Shah KV: The epidemiology of SV40 infection due to contaminated polio vaccines: relation of the virus to human cancer. In Human Polyomaviruses: Molecular and Clinical Perspectives. Edited by Khalili K, Stoner GL. New York: Wiley-Liss, Inc.; 2001:561–584.

    Google Scholar 

  17. Proceedings of the Second International Conference on Live Poliovirus Vaccines. Washington, DC: Pan American Health Organization Scientific Publication No. 50; 1960.

  18. Sullivan CS, Pipas JM: T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis. Microbiol Mol Biol Rev 2002, 66:179–202. A comprehensive review of the properties and functions of SV40 T antigens in viral infection and oncogenesis.

    Article  PubMed  CAS  Google Scholar 

  19. Sáenz-Robles MT, Sullivan CS, Pipas JM: Transforming functions of simian virus 40. Oncogene 2001, 20:7899–7907.

    Article  PubMed  Google Scholar 

  20. Jasani B, Cristaudo A, Emri SA, et al.: Association of SV40 with human tumours. Semin Cancer Biol 2001, 11:49–61. This is a comprehensive review of the molecular data from multiple studies indicating an association of SV40 with selected human cancers.

    Article  PubMed  CAS  Google Scholar 

  21. Arrington AS, Butel JS: SV40 and human tumors. In Human Polyomaviruses: Molecular and Clinical Perspectives. Edited by Khalili K, Stoner GL. New York: John Wiley & Sons; 2001:461–489.

    Google Scholar 

  22. Gazdar AF, Butel JS, Carbone M: SV40 and human tumours: myth, association or causality? Nat Rev Cancer 2002, 2:957–964. This report provides an analysis of the evidence of SV40 in human cancers. It suggests that SV40 should be categorized as a group 2A carcinogen, according to the recommendations of the International Agency for Research in Cancer.

    Article  PubMed  CAS  Google Scholar 

  23. Butel JS, Jafar S, Wong C, et al.: Evidence of SV40 infections in hospitalized children. Hum Pathol 1999, 30:1496–1502.

    Article  PubMed  CAS  Google Scholar 

  24. Li RM, Branton MH, Tanawattanacharoen S, et al.: Molecular identification of SV40 infection in human subjects and possible association with kidney disease. J Am Soc Nephrol 2002, 13:2320–2330. This study provides molecular evidence of current SV40 infections in the human population. It shows that the kidney may be a reservoir for this DNA tumor virus.

    Article  PubMed  CAS  Google Scholar 

  25. Martini F, Lazzarin L, Iaccheri L, et al.: Different simian virus 40 genomic regions and sequences homologous with SV40 large T antigen in DNA of human brain and bone tumors and of leukocytes from blood donors. Cancer 2002, 94:1037–1048.

    Article  PubMed  CAS  Google Scholar 

  26. Martini F, Iaccheri L, Lazzarin L, et al.: SV40 early region and large T antigen in human brain tumors, peripheral blood cells, and sperm fluids from healthy individuals. Cancer Res 1996, 56:4820–4825.

    PubMed  CAS  Google Scholar 

  27. Li RM, Mannon RB, Kleiner D, et al.: BK virus and SV40 coinfection in polyomavirus nephropathy. Transplantation 2002, 74:1497–1504. A study that provides additional evidence of SV40 infections in humans today.

    Article  PubMed  Google Scholar 

  28. Dolcetti R, Martini F, Quaia M, et al.: Simian virus 40 sequences in human lymphoblastoid B-cell lines. J Virol 2003, 77:1595–1597. This study provides evidence of the lymphomagenic capacity of SV40 in humans.

    Article  PubMed  CAS  Google Scholar 

  29. Breau WC, Atwood WJ, Norkin LC: Class I major histocompatibility proteins are an essential component of the simian virus 40 receptor. J Virol 1992, 66:2037–2045.

    PubMed  CAS  Google Scholar 

  30. Atwood WJ, Norkin LC: Class I major histocompatibility proteins as cell surface receptors for simian virus 40. J Virol 1989, 63:4474–4477.

    PubMed  CAS  Google Scholar 

  31. Staudt LM, Wilson WH: Focus on lymphomas. Cancer Cell 2002, 2:363–366.

    Article  PubMed  CAS  Google Scholar 

  32. Bocchetta M, Di Resta I, Powers A, et al.: Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci U S A 2000, 97:10214–10219.

    Article  PubMed  CAS  Google Scholar 

  33. Cacciotti P, Libener R, Betta P, et al.: SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma. Proc Natl Acad Sci U S A 2001, 98:12032–12037.

    Article  PubMed  CAS  Google Scholar 

  34. Foddis R, De Rienzo A, Broccoli D, et al.: SV40 infection induces telomerase activity in human mesothelial cells. Oncogene 2002, 21:1434–1442.

    Article  PubMed  CAS  Google Scholar 

  35. Rizzo P, Bocchetta M, Powers A, et al.: SV40 and the pathogenesis of mesothelioma. Semin Cancer Biol 2001, 11:63–71.

    Article  PubMed  CAS  Google Scholar 

  36. Toyooka S, Carbone M, Toyooka KO, et al.: Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells. Oncogene 2002, 21:4340–4344.

    Article  PubMed  CAS  Google Scholar 

  37. Bocchetta M, Miele L, Pass HI, Carbone M: Notch-1 induction, a novel activity of SV40 required for growth of SV40-transformed human mesothelial cells. Oncogene 2003, 22:81–89.

    Article  PubMed  CAS  Google Scholar 

  38. Bishop JM: The molecular genetics of cancer. Science 1987, 235:305–311.

    Article  PubMed  CAS  Google Scholar 

  39. Kuppers R, Dalla-Favera R: Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 2001, 20:5580–5594.

    Article  PubMed  CAS  Google Scholar 

  40. Classon M, Henriksson M, Sümegi J, et al.: Elevated c-myc expression facilitates the replication of SV40 DNA in human lymphoma cells. Nature 1987, 330:272–274.

    Article  PubMed  CAS  Google Scholar 

  41. Hahn WC, Dessain SK, Brooks MW, et al.: Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 2002, 22:2111–2123. An analysis of transformation of human cells by SV40 showing that both large and small T antigens are required.

    Article  PubMed  CAS  Google Scholar 

  42. Carbone M, Stach R, Di Resta I, et al.: Simian virus 40 oncogenesis in hamsters. Dev Biol Stand 1998, 94:273–279.

    PubMed  CAS  Google Scholar 

  43. Diamandopoulos GT: Leukemia, lymphoma, and osteosarcoma induced in the Syrian golden hamster by simian virus 40. Science 1972, 176:173–175.

    Article  PubMed  CAS  Google Scholar 

  44. Diamandopoulos GT: Induction of lymphocytic leukemia, lymphosarcoma, reticulum cell sarcoma, and osteogenic sarcoma in the Syrian golden hamster by oncogenic DNA simian virus 40. J Natl Cancer Inst 1973, 50:1347–1365.

    PubMed  CAS  Google Scholar 

  45. Coe JE, Green I: B-cell origin of hamster lymphoid tumors induced by simian virus 40. J Natl Cancer Inst 1975, 54:269–270.

    PubMed  CAS  Google Scholar 

  46. Cicala C, Pompetti F, Nguyen P, et al.: SV40 small t deletion mutants preferentially transform mononuclear phagocytes and B lymphocytes in vivo. Virology 1992, 190:475–479.

    Article  PubMed  CAS  Google Scholar 

  47. Kanki T: Immortalization of human primary B lymphocytes by simian virus 40 early region DNA. Hybridoma 1994, 13:327–330.

    PubMed  CAS  Google Scholar 

  48. Vilchez RA, Lednicky JA, Halvorson SJ, et al.: Detection of polyomavirus simian virus 40 tumor antigen DNA in AIDSrelated systemic non-Hodgkin lymphoma. J Acquir Immune Defic Syndr 2002, 29:109–116.

    PubMed  CAS  Google Scholar 

  49. Jaffe ES, Harris NL, Stein H, Vardiman JW: World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.

    Google Scholar 

  50. Shivapurkar N, Takahashi T, Reddy J, et al.: Presence of SV40 DNA sequences in human lymphoid and hematopoietic malignancies and its relationship to methylation of multiple genes [abstract 5155]. Proc Am Assoc Cancer Res 2003, 44:1181.

    Google Scholar 

  51. Rizzo P, Di Resta I, Powers A, et al.: Unique strains of SV40 in commercial poliovaccines from 1955 not readily identifiable with current testing for SV40 infection. Cancer Res 1999, 59:6103–6108.

    PubMed  CAS  Google Scholar 

  52. Bergsagel DJ, Finegold MJ, Butel JS, et al.: DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N Engl J Med 1992, 326:988–993.

    Article  PubMed  CAS  Google Scholar 

  53. Suzuki SO, Mizoguchi M, Iwaki T: Detection of SV40 T antigen genome in human gliomas. Brain Tumor Pathol 1997, 14:125–129.

    Article  PubMed  CAS  Google Scholar 

  54. Zhen HN, Zhang X, Bu XY, et al.: Expression of the simian virus 40 large tumor antigen (Tag) and formation of Tag-p53 and Tag-pRb complexes in human brain tumors. Cancer 1999, 86:2124–2132.

    Article  PubMed  CAS  Google Scholar 

  55. Weggen S, Bayer TA, Von Deimling A, et al.: Low frequency of SV40, JC and BK polyomavirus sequences in human medulloblastomas, meningiomas and ependymomas. Brain Pathol 2000, 10:85–92.

    Article  PubMed  CAS  Google Scholar 

  56. Malkin D, Chilton-MacNeill S, Meister LA, et al.: Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome. Oncogene 2001, 20:4441–4449.

    Article  PubMed  CAS  Google Scholar 

  57. Carbone M, Rizzo P, Procopio A, et al.: SV40-like sequences in human bone tumors. Oncogene 1996, 13:527–535.

    PubMed  CAS  Google Scholar 

  58. Mendoza SM, Konishi T, Miller CW: Integration of SV40 in human osteosarcoma DNA. Oncogene 1998, 17:2457–2462.

    Article  PubMed  CAS  Google Scholar 

  59. Yamamoto H, Nakayama T, Murakami H, et al.: High incidence of SV40-like sequences detection in tumour and peripheral blood cells of Japanese osteosarcoma patients. Br J Cancer 2000, 82:1677–1681.

    Article  PubMed  CAS  Google Scholar 

  60. Capello D, Rossi D, Gaudino G, et al.: Simian virus 40 infection in lymphoproliferative disorders. Lancet 2003, 361:88–89.

    Article  PubMed  Google Scholar 

  61. Engels EA, Katki HA, Nielsen NM, et al.: Cancer incidence in Denmark following exposure to poliovirus vaccine contaminated with simian virus 40. J Natl Cancer Inst 2003, 95:532–539.

    Article  PubMed  CAS  Google Scholar 

  62. Vilchez RA, Butel JS: SV40 in human brain cancers and non-Hodgkin’s lymphoma. Oncogene Rev 2003, in press.

  63. Howley PM, Lowy DR: Papillomaviruses and their replication. In Field’s Virology. Edited by Knipe DM, Howley PM, Griffin DE, et al. Philadelphia: Lippincott Williams & Wilkins; 2001:2197–2229.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine (RAV), Molecular Virology, and Microbiology (JSB), Baylor College of Medicine, One Baylor Plaza, Mail Stop BCM-385, 77030, Houston, TX, USA

    Regis A. Vilchez MD & Janet S. Butel PhD

Authors
  1. Regis A. Vilchez MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Janet S. Butel PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vilchez, R.A., Butel, J.S. Simian virus 40 and its association with human lymphomas. Curr Oncol Rep 5, 372–379 (2003). https://doi.org/10.1007/s11912-003-0021-y

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-003-0021-y

Keywords

Search

Navigation